IP Library Granted Patent US 8,383,380
Granted Patent B2
US 8,383,380 · App. 13/267,619 · Granted Feb 26, 2013

Segmented polymers and their conjugates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,383,380
App. No.
13/267,619
Granted
Feb 26, 2013
Kind
B2
Abstract

Segmented water soluble polymers, containing a higher molecular weight segment linked to a lower molecular weight segment, are described. In one embodiment, the polymer segments are poly(ethylene glycol) segments. The segmented polymers are functionalized and are useful for conjugation to various moieties such as pharmacologically active substances. Also described are conjugates of such polymers and methods of their preparation.

Claims (28)

1. A composition comprising (i) a pharmaceutical carrier and (ii) a conjugate of a water soluble polymer and a pharmacologically active agent, wherein the pharmacologically active agent is attached to the water soluble polymer via a functional group Y, wherein the water soluble polymer has a structure encompassed within the following formula:

wherein:

each PEG is a poly(ethylene glycol) segment having a molecular weight ranged of from about 15000 to about 50000;

X is —NH—;

POLY B is a water soluble segment comprising 1 to about 120 monomeric units, which has a lower molecular weight than that of each PEG;

[Spacer Group] is a group linking Y to a terminus of POLY B ; and

Y is functional group.

2. The composition of claim 1 , wherein POLY B comprises one monomer or up to three different monomers selected from the group consisting of alkylene glycol, olefinic alcohol, vinylpyrrolidone, hydroxyalkylmethacrylamide, hydroxyalkylmethacrylate, saccharide, α-hydroxy acid, phosphazene, oxazoline, and N-acryloylmorpholine.

3. The composition of claim 1 , wherein the molecular weight of each PEG is at least twice that of POLY B .

4. The composition of claim 1 , wherein POLY B comprises at least 2 monomeric units.

5. The composition of claim 1 , wherein POLY B is a poly(alkylene glycol) segment.

6. The composition of claim 5 , wherein POLY B is a poly(ethylene glycol) segment.

7. The composition of claim 1 , wherein POLY B is poly(ethylene glycol) segment having a molecular weight selected from the group consisting of about 88, about 132, about 176 and about 220.

8. The composition of claim 1 , wherein the Spacer Group is a hydrolytically stable group.

9. The composition of claim 1 , wherein the Spacer Group is a hydrocarbon spacer.

10. The composition of claim 9 , wherein the hydrocarbon spacer is a linear divalent alkyl chain.

11. The composition of claim 10 , wherein the linear divalent alkyl chain has 4 to about 8 carbons.

12. The composition of claim 1 , wherein Y is a nucleophilic group.

13. The composition of claim 12 , wherein Y is selected from the group consisting of hydroxyl, amine, hydrazine, hydrazide and thiol.

14. The composition of claim 1 , wherein Y is an electrophilic group.

15. The composition of claim 14 , wherein the electrophilic group is selected from the group consisting of carboxylic acid, carboxylic ester, imide ester, orthoester, carbonate, isocyanate, isothiocyanate, aldehyde, ketone, thione, alkenyl, acrylate, methacrylate, acrylamide, sulfone, maleimide, disulfide, iodo, epoxy, sulfonate, thiosulfonate, silane, alkoxysilane, halosilane and phosphoramidate.

16. The composition of claim 15 , wherein the electrophilic group is a carboxylic acid.

17. The composition of claim 15 , wherein the electrophilic group is a carboxylic ester.

18. The composition of claim 15 , wherein the electrophilic group is an aldehyde.

19. The composition of claim 15 , wherein the electrophilic group is a maleimide.

20. The composition of claim 1 , wherein the each PEG is end-capped with a capping group selected from the group consisting of C 1 -C 20 alkoxy, C 1 -C 20 aryloxy and a phospholipid.

21. The composition of claim 20 , wherein the capping group is C 1 -C 5 alkoxy.

22. The composition of claim 21 , wherein the capping group is methoxy.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →